Many bone-derived factors have been discovered, but here, we mainly focus on four bone factors that have a regulatory effect on muscles, namely, osteocalcin, IGF-1, RANKL and FGF-23, and seek to understand their possible therapeutic targets in sarcopenia. The gene discussed is TNFSF11; the disease is sarcopenia.